Argent Biopharma Limited has released a press release.
ArtemiC Phase II Clinical Trial Results
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Argent Biopharma
- Prospectus
- Mgc pharma completes acquisition of telehealth platform mcc
- Further successful results from glioblastoma research
- Completion of phase ii clinical trial on covid-19 patients
- September Quarterly Activity and Cashflow Report
Later from Argent Biopharma
- December Quarterly Activity and Cashflow Report
- MGC Pharma Investor Presentation
- MGC Pharma first medicinal cannabis company to list on LSE
- SwissPharmaCan AG increases initial purchase order
- Ethics Committee Approval Granted Phase III Clinical Trial
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma